Cargando…
Immune-Related Adverse Events: Pneumonitis
Checkpoint inhibitors are part of the family of immunotherapies and are increasingly being used in a wide variety of cancers. Immune-related adverse events pose a major challenge in the treatment of cancer patients. Pneumonitis is a rare immune-related adverse event that presents in distinct pattern...
Autores principales: | Zhong, Linda, Altan, Mehmet, Shannon, Vickie R., Sheshadri, Ajay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161534/ https://www.ncbi.nlm.nih.gov/pubmed/32301020 http://dx.doi.org/10.1007/978-3-030-41008-7_13 |
Ejemplares similares
-
Two Cases of Nivolumab Re-Administration after Pneumonitis as Immune-Related Adverse Events
por: Imafuku, Keisuke, et al.
Publicado: (2017) -
Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept
por: Aminu, Muhammad, et al.
Publicado: (2023) -
Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature
por: Soto, Felipe, et al.
Publicado: (2023) -
Hypercalcemia with methotrexate pneumonitis: A rare, important and intriguing adverse event
por: Samant, R, et al.
Publicado: (2022) -
Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience
por: Altan, Mehmet, et al.
Publicado: (2023)